An exploratory clinical study on the safety of combination therapy with effector cell therapy and immune checkpoint inhibitors.
Not Applicable
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000028756
- Lead Sponsor
- KOUSHIKAI,Non-profitmedicalcorporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
A patient MUST NOT: (1)Have treated with immune checkpoint inhibitors. (2)Be a female who is pregnant, lactating, or with a possibility of pregnancy. (3)Be determined to be inappropriate by the doctor in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method